BillionToOne YC Başvurusu

Summer 2017Public

BillionToOne, Healthcare şirketi olarak Summer 2017 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Summer 2017
Sektör: HealthcareDiagnostics
Ekip büyüklüğü: 300
Durum: Public
Lansmanı Yapıldı: 2016

Kurucular

Oguzhan AtayFounder
David TsaoFounder/CTO

BillionToOne ne yapar

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

BillionToOne'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

BillionToOne, Summer 2017 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

BillionToOne

Describe what your company does in 50 characters or less.

The genetic testing platform detecting and measuring disease.

What is your company going to make? Please describe your product and what it does or will do.

We have built a DNA molecular counter that improves the resolution of cell-free DNA diagnostics by over a thousand times. Our main product, UNITY Screen, is a non-invasive prenatal test that uniquely assesses fetal risk for recessive conditions and chromosomal abnormalities from maternal blood. We are expanding this technology into liquid biopsy tests for cancer, aiming to transform how oncology care detects and monitors disease.

Where do you live now, and where would the company be based after YC?

We currently live and work in Menlo Park, CA, and would keep the company based there after YC.

Explain your decision regarding location.

We are based in Menlo Park because it provides access to top scientific talent and proximity to leading healthcare and biotech partners, which is critical for developing and refining our complex diagnostics technology.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, BillionToOne şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, BillionToOne'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. BillionToOne gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.